Higher colonic tissue drug concentrations of subcutaneous compared to intravenous infliximab administration in patients with Inflammatory Bowel Disease. - Roblin, X.; Nancey, S.; Barrau, M.; Papamichail, K.; Cheifetz, A.; Paul, S. (Journal of Crohn's & Colitis, 2026)